CHRISTINE NORTON: Open Payments
NPI 1427350420 · HENDERSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,555 in 69 payments from 10 companies in 2025. Trend: 2023 $1,150 · 2024 $1,198 · 2025 $1,555
Food & beverage: $1,443Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $374 |
| Neurocrine BioSciences, Inc. | 12 | $306 |
| Alkermes, Inc. | 16 | $291 |
| Teva Pharmaceuticals USA, Inc. | 9 | $257 |
| Otsuka America Pharmaceutical, Inc. | 11 | $162 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| ABBVIE INC. | 1 | $30 |
| Lundbeck LLC | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: COBENFY, INGREZZA, ARISTADA, REXULTI, UZEDY, ABILIFY ASIMTUFII, AUSTEDO XR, FANAPT.
Industry payments across NC — which companies pay providers there.
